Breaking
CNFocus Stocks》00673R: International oil prices plummeted, crude oil opened against 1 and surged in volumeCNNASA's Swift satellite flew over Indonesia, crashed into the atmosphere at 22 times the speed of sound and burned upCNLINE officially issues an important announcement! If you don’t need to do one less account setting, all your friends and chat history may disappear.JPNationwide network for fraud prevention 807 Sharing information with financial institutions - Preventing damage from spreading through public-private collaboration / National Police AgencyCNFocus Stocks》Handa: The original manufacturer filed a patent lawsuit and suffered continuous lossesCNBei City promotes low-carbon diet parade. 11/7 Zhongzheng District Traffic Control, look here!CNVisiting the famous tea village, Bajiong calls on young people to go home and vote to protect the tea industryCNThe Chinese Consulate General in Los Angeles reminds Chinese citizens to be careful when choosing to enter Honolulu International AirportCNAttention passers-by! Nanchang Family Reunion Festival in Beijing City debuts on the weekend, and the second section of Nanchang Road is closedKRHeavy rain in November... Heavy rain exceeding 50 mm per hour in eastern Jeju last nightCNFocus Stocks》00673R: International oil prices plummeted, crude oil opened against 1 and surged in volumeCNNASA's Swift satellite flew over Indonesia, crashed into the atmosphere at 22 times the speed of sound and burned upCNLINE officially issues an important announcement! If you don’t need to do one less account setting, all your friends and chat history may disappear.JPNationwide network for fraud prevention 807 Sharing information with financial institutions - Preventing damage from spreading through public-private collaboration / National Police AgencyCNFocus Stocks》Handa: The original manufacturer filed a patent lawsuit and suffered continuous lossesCNBei City promotes low-carbon diet parade. 11/7 Zhongzheng District Traffic Control, look here!CNVisiting the famous tea village, Bajiong calls on young people to go home and vote to protect the tea industryCNThe Chinese Consulate General in Los Angeles reminds Chinese citizens to be careful when choosing to enter Honolulu International AirportCNAttention passers-by! Nanchang Family Reunion Festival in Beijing City debuts on the weekend, and the second section of Nanchang Road is closedKRHeavy rain in November... Heavy rain exceeding 50 mm per hour in eastern Jeju last night
Newsgather
All StoriesWorldSportsFinanceTechScienceHealthCultureClimatePoliticsSpace
BackFocus Stocks》Handa: The original manufacturer filed a patent lawsuit and suffered continuous losses
Focus Stocks》Handa: The original manufacturer filed a patent lawsuit and suffered continuous losses
Urgent
自由时报8 minutes agoBusiness2 min readChinaView original

Focus Stocks》Handa: The original manufacturer filed a patent lawsuit and suffered continuous losses

A new multi-target cancer drug was sued by Exelixis, causing the stock price to jump below the limit and tighten the limit.

Handa BiotechnologyHND-039Exelixis

Quick Look

  • HND-039, a new multi-target cancer drug developed by Handa Biotech, was sued by the original manufacturer Exelixis for a U.S. patent lawsuit, causing the stock price to hit two limits in a row, locking the limit at 100.5 yuan today.
  • The new drug obtained FDA marketing approval in August and was originally expected to be launched in the United States in the fourth quarter.
  • It will share an annual market value of US$2.1 billion with the original manufacturer.

AI-generated summary

Why It Matters

Handa Biotechnology is a company focused on the development of special generic drugs. HND-039 is its multi-target cancer 505(b)(2) new drug. It obtained the US FDA marketing approval in August. It was originally expected to be launched in the US in the fourth quarter of this year and will share an annual market value of US$2.1 billion with the original manufacturer.

Font size

Liu Fangyu, Chairman of Handa Biotechnology. (File photo)

[Reporter Chen Yongji/Taipei Report] Handa Biotechnology (6620), which focuses on the development of special generic drugs, announced after the market yesterday (4) that the company’s multi-target cancer 505(b)(2) new drug HND-039 was sued by the original manufacturer Exelixis for a U.S. patent lawsuit, causing Handa’s stock price to jump to the limit today. In addition, it had "preliminarily" dropped to the limit yesterday, which means it has hit two limits in a row.

As of 9:46 today, Handa's stock price locked at the lower limit of 100.5 yuan, with a trading volume of 1,189 contracts, and about 1,200 contracts for sale at the lower limit.

HND-039, which originally had high hopes for Handa, obtained the marketing authorization issued by the US FDA in August. It was originally expected to be launched in the United States in the fourth quarter of this year. Apart from the original drug, there are no other generic drug competitors. It will share an annual market value of US$2.1 billion (approximately NT$68 billion) with the original manufacturer, driving Handa's stock price to rise to 155 yuan in mid-September.

In response to this patent lawsuit, Handa pointed out that in the U.S. pharmaceutical market, companies may file patent lawsuits based on patent claims. Such patent disputes are a normal competition in the U.S. pharmaceutical industry. The company has always attached great importance to the protection of intellectual property rights and has been fully prepared. The company will continue to carry out the original product launch planning and business development strategy.

What to Watch

AI outlook — possibilities, not facts

  • Handa Biotechnology will continue to carry out HND-039 product launch planning and business development strategies

    Likely · Within weeks

Open Questions

  • What are the specific contents and progress of patent litigation?
  • Will the U.S. launch of HND-039 be delayed?
  • How will Handa Biotech respond to patent litigation?

Related Topics

Handa Biotechnology
PeopleLiu Fangyu
OrganizationsExelixisUSFDA
PlacesTaipeiUnited States
TopicsHND-039Exelixispatent litigationLimit downGeneric medicineFDA
This article was originally published by 自由时报.

Related Stories

Many indicators hit new highs, and the CIIE is expected to yield fruitful results
Developing·

Many indicators hit new highs, and the CIIE is expected to yield fruitful results

The 9th China International Import Expo opened at the National Convention and Exhibition Center (Shanghai) on November 5. 162 countries, regions and international organizations participated, and 4,142 overseas companies participated in the exhibition. The overall area exceeded 440,000 square meters for the first time, and the number of Fortune 500 and industry leading companies exceeded 300 for the first time.

中国新闻网
5 min read
The Democrats swept Congress and the U.S. stock market was reshuffled! AI stocks plunged more than 23%, but "such stocks" soared
Urgent·

The Democrats swept Congress and the U.S. stock market was reshuffled! AI stocks plunged more than 23%, but "such stocks" soared

After the U.S. midterm elections, the Democratic Party regained control of the House and Senate, and U.S. stocks experienced sector rotation. AI data center stocks were sold off, with Hut 8 falling 23.23%, Cipher Digital falling 19.95%, Galaxy Digital falling 16.99%; Trump Media and Technology Group plummeting 24.54%. Medical stocks bucked the trend and rose, with Centene rising 12.64%, HCA Healthcare soaring 10.34%, Universal Health Services rising 10.88%, and Molina Healthcare rising 8.89%. Clean energy stocks were also favored, with First Solar rising 4.63%, Enphase Energy rising 3.71%, and NextEra Energy rising 4.89%. Large cloud players bucked the trend and rose, with Microsoft rising 6.68%, Amazon rising 6.12%, and Alphabet rising 3.18%. Defense stocks generally weakened, with Lockheed Martin falling 6.92%, L3Harris falling 6.41%, and Northrop Grumman falling 4.53%.

自由时报
3 min read
Listed banks have incorporated more than 40 rural banks during the year
Developing·

Listed banks have incorporated more than 40 rural banks during the year

Since the beginning of this year, many listed banks such as Bank of Communications, Minsheng Bank, Shanghai Pudong Development Bank, and Bank of Guizhou have promoted the acquisition and merger of rural banks, and a total of more than 40 have been approved. Bank of Guizhou plans to reform the remaining 10 rural banks using the “acceptance + exit” approach. Industry insiders pointed out that after integration, it is necessary to prevent the weakening of financial supply in counties and maintain the positioning of supporting agriculture and small businesses.

中国新闻网
6 min read
Trump's defeat shocks global stock markets! Xie Jinhe reveals "4 crises": Taiwan stock market is still the strongest market
Developing·

Trump's defeat shocks global stock markets! Xie Jinhe reveals "4 crises": Taiwan stock market is still the strongest market

The Democratic Party won a huge victory in the U.S. midterm elections and gained control of the House and Senate. Trump suffered a major setback. Xie Jinhe, chairman of Caixin Media, pointed out that factors such as AI capital expenditures, corporate financial reports and competition in the memory industry are putting pressure on global stock markets. However, Taiwan stocks are still the strongest market this year, and it may have to wait until next year to challenge 50,000 points.

自由时报
3 min read
More on this topicHanda Biotechnology